# Evaluation of the Efficacy and Safety of Surgical Device Lymphoblock for Prevention of Lymphorrhea in Patients With Thoracoabdominal Aorta Repair.

Study · id `cardio:ct-nct06286540` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06286540](<https://clinicaltrials.gov/study/NCT06286540>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT06286540

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 138 participants.

## Technical summary

Registry record NCT06286540. Randomized; double masking; primary purpose prevention. Start 2023-02-22 (actual); primary completion 2026-02 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose prevention
- Phase: Not applicable
- Enrolled: 138 participants (planned count; ClinicalTrials.gov record NCT06286540, source copy `cardio:ctgov-nct06286540-2024-03-15`, retrieved 2026-11-18)
- Started: 2023-02-22 (actual) (ClinicalTrials.gov record NCT06286540, source copy `cardio:ctgov-nct06286540-2024-03-15`, retrieved 2026-11-18)
- Primary completion: 2026-02 (anticipated) (ClinicalTrials.gov record NCT06286540, source copy `cardio:ctgov-nct06286540-2024-03-15`, retrieved 2026-11-18)
- Completion: 2026-05 (anticipated) (ClinicalTrials.gov record NCT06286540, source copy `cardio:ctgov-nct06286540-2024-03-15`, retrieved 2026-11-18)
- Countries: Russia (ClinicalTrials.gov record NCT06286540, source copy `cardio:ctgov-nct06286540-2024-03-15`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06286540-2024-03-15`, retrieved 2026-11-18)

## The registry's words

- Brief title: Evaluation of the Efficacy and Safety of Surgical Device "Lymphoblock" for Prevention of Lymphorrhea in Patients With Thoracoabdominal Aorta Repair.
- Condition: Aorta Abdominalis; Aneurysm
- Condition: Aorta Thoracic; Aneurysm
- Intervention (Device): Lymphoblock
- Intervention (Device): Placebo
- Lead sponsor: Petrovsky National Research Centre of Surgery
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Abdominal aortic aneurysm (`cardio:abdominal-aortic-aneurysm`)
- Registry condition terms include this condition: Aortic aneurysm (`cardio:aortic-aneurysm`)
- Registry condition terms include this condition: Thoracic aortic aneurysm (`cardio:thoracic-aortic-aneurysm`)

## Provenance

Content hash: e664ef892f0991c5a9e3c2a3351fd89f53976f7fde30a1a3d6e596c90715ecfc
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
